Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Intramuscular Injection
1.2.4 Others
1.3 Market by Application
1.3.1 Global Acute Agitation and Aggression Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals & Ambulatory Surgical Centers
1.3.3 Psychiatric Care Facilities
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Agitation and Aggression Drugs Market Perspective (2018-2029)
2.2 Acute Agitation and Aggression Drugs Growth Trends by Region
2.2.1 Global Acute Agitation and Aggression Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Acute Agitation and Aggression Drugs Historic Market Size by Region (2018-2024)
2.2.3 Acute Agitation and Aggression Drugs Forecasted Market Size by Region (2024-2029)
2.3 Acute Agitation and Aggression Drugs Market Dynamics
2.3.1 Acute Agitation and Aggression Drugs Industry Trends
2.3.2 Acute Agitation and Aggression Drugs Market Drivers
2.3.3 Acute Agitation and Aggression Drugs Market Challenges
2.3.4 Acute Agitation and Aggression Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Agitation and Aggression Drugs Players by Revenue
3.1.1 Global Top Acute Agitation and Aggression Drugs Players by Revenue (2018-2024)
3.1.2 Global Acute Agitation and Aggression Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Acute Agitation and Aggression Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Agitation and Aggression Drugs Revenue
3.4 Global Acute Agitation and Aggression Drugs Market Concentration Ratio
3.4.1 Global Acute Agitation and Aggression Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Agitation and Aggression Drugs Revenue in 2022
3.5 Acute Agitation and Aggression Drugs Key Players Head office and Area Served
3.6 Key Players Acute Agitation and Aggression Drugs Product Solution and Service
3.7 Date of Enter into Acute Agitation and Aggression Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Agitation and Aggression Drugs Breakdown Data by Type
4.1 Global Acute Agitation and Aggression Drugs Historic Market Size by Type (2018-2024)
4.2 Global Acute Agitation and Aggression Drugs Forecasted Market Size by Type (2024-2029)
5 Acute Agitation and Aggression Drugs Breakdown Data by Application
5.1 Global Acute Agitation and Aggression Drugs Historic Market Size by Application (2018-2024)
5.2 Global Acute Agitation and Aggression Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Acute Agitation and Aggression Drugs Market Size (2018-2029)
6.2 North America Acute Agitation and Aggression Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Acute Agitation and Aggression Drugs Market Size by Country (2018-2024)
6.4 North America Acute Agitation and Aggression Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Agitation and Aggression Drugs Market Size (2018-2029)
7.2 Europe Acute Agitation and Aggression Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Acute Agitation and Aggression Drugs Market Size by Country (2018-2024)
7.4 Europe Acute Agitation and Aggression Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Agitation and Aggression Drugs Market Size (2018-2029)
8.2 Asia-Pacific Acute Agitation and Aggression Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Region (2018-2024)
8.4 Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Agitation and Aggression Drugs Market Size (2018-2029)
9.2 Latin America Acute Agitation and Aggression Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Acute Agitation and Aggression Drugs Market Size by Country (2018-2024)
9.4 Latin America Acute Agitation and Aggression Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Agitation and Aggression Drugs Market Size (2018-2029)
10.2 Middle East & Africa Acute Agitation and Aggression Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country (2018-2024)
10.4 Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Detail
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Acute Agitation and Aggression Drugs Introduction
11.1.4 Eli Lilly and Company Revenue in Acute Agitation and Aggression Drugs Business (2018-2024)
11.1.5 Eli Lilly and Company Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Acute Agitation and Aggression Drugs Introduction
11.2.4 Pfizer Revenue in Acute Agitation and Aggression Drugs Business (2018-2024)
11.2.5 Pfizer Recent Development
11.3 Ono Pharmaceutical
11.3.1 Ono Pharmaceutical Company Detail
11.3.2 Ono Pharmaceutical Business Overview
11.3.3 Ono Pharmaceutical Acute Agitation and Aggression Drugs Introduction
11.3.4 Ono Pharmaceutical Revenue in Acute Agitation and Aggression Drugs Business (2018-2024)
11.3.5 Ono Pharmaceutical Recent Development
11.4 Otsuka Holdings
11.4.1 Otsuka Holdings Company Detail
11.4.2 Otsuka Holdings Business Overview
11.4.3 Otsuka Holdings Acute Agitation and Aggression Drugs Introduction
11.4.4 Otsuka Holdings Revenue in Acute Agitation and Aggression Drugs Business (2018-2024)
11.4.5 Otsuka Holdings Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Acute Agitation and Aggression Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Acute Agitation and Aggression Drugs Business (2018-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Acute Agitation and Aggression Drugs Introduction
11.6.4 Bristol-Myers Squibb Revenue in Acute Agitation and Aggression Drugs Business (2018-2024)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Acute Agitation and Aggression Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Acute Agitation and Aggression Drugs Business (2018-2024)
11.7.5 Johnson & Johnson Recent Development
11.8 H. Lundbeck A/S
11.8.1 H. Lundbeck A/S Company Detail
11.8.2 H. Lundbeck A/S Business Overview
11.8.3 H. Lundbeck A/S Acute Agitation and Aggression Drugs Introduction
11.8.4 H. Lundbeck A/S Revenue in Acute Agitation and Aggression Drugs Business (2018-2024)
11.8.5 H. Lundbeck A/S Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Intramuscular Injection
Table 4. Key Players of Others
Table 5. Global Acute Agitation and Aggression Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Acute Agitation and Aggression Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Acute Agitation and Aggression Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Acute Agitation and Aggression Drugs Market Share by Region (2018-2024)
Table 9. Global Acute Agitation and Aggression Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Acute Agitation and Aggression Drugs Market Share by Region (2024-2029)
Table 11. Acute Agitation and Aggression Drugs Market Trends
Table 12. Acute Agitation and Aggression Drugs Market Drivers
Table 13. Acute Agitation and Aggression Drugs Market Challenges
Table 14. Acute Agitation and Aggression Drugs Market Restraints
Table 15. Global Acute Agitation and Aggression Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Acute Agitation and Aggression Drugs Market Share by Players (2018-2024)
Table 17. Global Top Acute Agitation and Aggression Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Agitation and Aggression Drugs as of 2022)
Table 18. Ranking of Global Top Acute Agitation and Aggression Drugs Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Acute Agitation and Aggression Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Acute Agitation and Aggression Drugs Product Solution and Service
Table 22. Date of Enter into Acute Agitation and Aggression Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute Agitation and Aggression Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Acute Agitation and Aggression Drugs Revenue Market Share by Type (2018-2024)
Table 26. Global Acute Agitation and Aggression Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Acute Agitation and Aggression Drugs Revenue Market Share by Type (2024-2029)
Table 28. Global Acute Agitation and Aggression Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Acute Agitation and Aggression Drugs Revenue Market Share by Application (2018-2024)
Table 30. Global Acute Agitation and Aggression Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Acute Agitation and Aggression Drugs Revenue Market Share by Application (2024-2029)
Table 32. North America Acute Agitation and Aggression Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Acute Agitation and Aggression Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Acute Agitation and Aggression Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Acute Agitation and Aggression Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Acute Agitation and Aggression Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Acute Agitation and Aggression Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Acute Agitation and Aggression Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Acute Agitation and Aggression Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Acute Agitation and Aggression Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Acute Agitation and Aggression Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Acute Agitation and Aggression Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 47. Eli Lilly and Company Company Detail
Table 48. Eli Lilly and Company Business Overview
Table 49. Eli Lilly and Company Acute Agitation and Aggression Drugs Product
Table 50. Eli Lilly and Company Revenue in Acute Agitation and Aggression Drugs Business (2018-2024) & (US$ Million)
Table 51. Eli Lilly and Company Recent Development
Table 52. Pfizer Company Detail
Table 53. Pfizer Business Overview
Table 54. Pfizer Acute Agitation and Aggression Drugs Product
Table 55. Pfizer Revenue in Acute Agitation and Aggression Drugs Business (2018-2024) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Ono Pharmaceutical Company Detail
Table 58. Ono Pharmaceutical Business Overview
Table 59. Ono Pharmaceutical Acute Agitation and Aggression Drugs Product
Table 60. Ono Pharmaceutical Revenue in Acute Agitation and Aggression Drugs Business (2018-2024) & (US$ Million)
Table 61. Ono Pharmaceutical Recent Development
Table 62. Otsuka Holdings Company Detail
Table 63. Otsuka Holdings Business Overview
Table 64. Otsuka Holdings Acute Agitation and Aggression Drugs Product
Table 65. Otsuka Holdings Revenue in Acute Agitation and Aggression Drugs Business (2018-2024) & (US$ Million)
Table 66. Otsuka Holdings Recent Development
Table 67. GlaxoSmithKline Company Detail
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline Acute Agitation and Aggression Drugs Product
Table 70. GlaxoSmithKline Revenue in Acute Agitation and Aggression Drugs Business (2018-2024) & (US$ Million)
Table 71. GlaxoSmithKline Recent Development
Table 72. Bristol-Myers Squibb Company Detail
Table 73. Bristol-Myers Squibb Business Overview
Table 74. Bristol-Myers Squibb Acute Agitation and Aggression Drugs Product
Table 75. Bristol-Myers Squibb Revenue in Acute Agitation and Aggression Drugs Business (2018-2024) & (US$ Million)
Table 76. Bristol-Myers Squibb Recent Development
Table 77. Johnson & Johnson Company Detail
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Acute Agitation and Aggression Drugs Product
Table 80. Johnson & Johnson Revenue in Acute Agitation and Aggression Drugs Business (2018-2024) & (US$ Million)
Table 81. Johnson & Johnson Recent Development
Table 82. H. Lundbeck A/S Company Detail
Table 83. H. Lundbeck A/S Business Overview
Table 84. H. Lundbeck A/S Acute Agitation and Aggression Drugs Product
Table 85. H. Lundbeck A/S Revenue in Acute Agitation and Aggression Drugs Business (2018-2024) & (US$ Million)
Table 86. H. Lundbeck A/S Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Agitation and Aggression Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Acute Agitation and Aggression Drugs Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Intramuscular Injection Features
Figure 5. Others Features
Figure 6. Global Acute Agitation and Aggression Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Acute Agitation and Aggression Drugs Market Share by Application: 2022 VS 2029
Figure 8. Hospitals & Ambulatory Surgical Centers Case Studies
Figure 9. Psychiatric Care Facilities Case Studies
Figure 10. Others Case Studies
Figure 11. Acute Agitation and Aggression Drugs Report Years Considered
Figure 12. Global Acute Agitation and Aggression Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Acute Agitation and Aggression Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Acute Agitation and Aggression Drugs Market Share by Region: 2022 VS 2029
Figure 15. Global Acute Agitation and Aggression Drugs Market Share by Players in 2022
Figure 16. Global Top Acute Agitation and Aggression Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Agitation and Aggression Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Acute Agitation and Aggression Drugs Revenue in 2022
Figure 18. North America Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Acute Agitation and Aggression Drugs Market Share by Country (2018-2029)
Figure 20. United States Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Acute Agitation and Aggression Drugs Market Share by Country (2018-2029)
Figure 24. Germany Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Acute Agitation and Aggression Drugs Market Share by Region (2018-2029)
Figure 32. China Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Acute Agitation and Aggression Drugs Market Share by Country (2018-2029)
Figure 40. Mexico Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Acute Agitation and Aggression Drugs Market Share by Country (2018-2029)
Figure 44. Turkey Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Acute Agitation and Aggression Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Eli Lilly and Company Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2018-2024)
Figure 47. Pfizer Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2018-2024)
Figure 48. Ono Pharmaceutical Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2018-2024)
Figure 49. Otsuka Holdings Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2018-2024)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2018-2024)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2018-2024)
Figure 52. Johnson & Johnson Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2018-2024)
Figure 53. H. Lundbeck A/S Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2018-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed